LEONARD BELL Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LEONARD BELL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LEONARD BELL. LEONARD BELL is CEO in ALEXION PHARMACEUTICALS INC ($ALXN) and CFO in ALEXION PHARMACEUTICALS INC ($ALXN) and Chief Executive Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and Director in MEDICINES CO /DE ($MDCO).
Latest Insider Trading Transactions of LEONARD BELL
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 22 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 140.94 | 2,287 | 322,330 | 1,043,662 | 1 M to 1 M (-0.22 %) |
Jan 22 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 140.14 | 30,402 | 4,260,536 | 1,045,949 | 1.1 M to 1 M (-2.82 %) |
Jan 22 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 6.90 | 32,689 | 225,554 | 1,076,351 | 1 M to 1.1 M (+3.13 %) |
Jan 15 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 6.90 | 15,845 | 109,331 | 60,500 | |
Jan 15 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 135.25 | 15,845 | 2,143,036 | 1,043,662 | 1.1 M to 1 M (-1.50 %) |
Jan 15 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 6.90 | 15,845 | 109,331 | 1,059,507 | 1 M to 1.1 M (+1.52 %) |
Jan 10 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 6.90 | 11,705 | 80,765 | 76,345 | |
Jan 10 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 6.90 | 1,039 | 7,169 | 88,050 | |
Jan 10 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 6.90 | 911 | 6,286 | 89,089 | |
Jan 10 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 5.18 | 5,500 | 28,490 | 0 | |
Jan 10 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 135.00 | 11,705 | 1,580,175 | 1,031,957 | 1 M to 1 M (-1.12 %) |
Jan 10 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 6.90 | 11,705 | 80,765 | 1,043,662 | 1 M to 1 M (+1.13 %) |
Jan 10 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 135.05 | 1,039 | 140,317 | 1,031,957 | 1 M to 1 M (-0.10 %) |
Jan 10 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 6.90 | 1,039 | 7,169 | 1,032,996 | 1 M to 1 M (+0.10 %) |
Jan 10 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 134.93 | 6,411 | 865,036 | 1,031,957 | 1 M to 1 M (-0.62 %) |
Jan 10 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 6.90 | 911 | 6,286 | 1,038,368 | 1 M to 1 M (+0.09 %) |
Jan 10 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 5.18 | 5,500 | 28,490 | 1,037,457 | 1 M to 1 M (+0.53 %) |
Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 5.18 | 35,000 | 181,300 | 5,500 | |
Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 17.65 | 5,664 | 99,970 | 0 | |
Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 5.18 | 57,500 | 297,850 | 40,500 | |
Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 5.10 | 82,500 | 420,750 | 0 | |
Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 129.90 | 35,000 | 4,546,500 | 1,031,957 | 1.1 M to 1 M (-3.28 %) |
Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 5.18 | 35,000 | 181,300 | 1,066,957 | 1 M to 1.1 M (+3.39 %) |
Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 128.59 | 14,415 | 1,853,625 | 1,031,957 | 1 M to 1 M (-1.38 %) |
Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 127.44 | 9,736 | 1,240,756 | 1,046,372 | 1.1 M to 1 M (-0.92 %) |
Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 126.33 | 5,872 | 741,810 | 1,056,108 | 1.1 M to 1.1 M (-0.55 %) |
Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 125.30 | 73,843 | 9,252,528 | 1,061,980 | 1.1 M to 1.1 M (-6.50 %) |
Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 124.31 | 24,273 | 3,017,377 | 1,135,823 | 1.2 M to 1.1 M (-2.09 %) |
Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 123.35 | 11,861 | 1,463,054 | 1,160,096 | 1.2 M to 1.2 M (-1.01 %) |
Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 17.65 | 5,664 | 99,970 | 1,171,957 | 1.2 M to 1.2 M (+0.49 %) |
Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 5.18 | 57,500 | 297,850 | 1,166,293 | 1.1 M to 1.2 M (+5.19 %) |
Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 5.10 | 82,500 | 420,750 | 1,108,793 | 1 M to 1.1 M (+8.04 %) |
Sep 18 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 115.00 | 3,500 | 402,500 | 1,026,293 | 1 M to 1 M (-0.34 %) |
Sep 06 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Gift | G | 0.00 | 28,124 | 0 | 1,029,793 | 1 M to 1 M (+2.81 %) |
Sep 06 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 110.07 | 1,850 | 203,630 | 1,001,669 | 1 M to 1 M (-0.18 %) |
Sep 03 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 111.06 | 2,100 | 233,226 | 1,003,519 | 1 M to 1 M (-0.21 %) |
Sep 03 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 110.15 | 28,558 | 3,145,664 | 1,005,619 | 1 M to 1 M (-2.76 %) |
Sep 03 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 109.92 | 500 | 54,960 | 1,034,177 | 1 M to 1 M (-0.05 %) |
Sep 03 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 109.93 | 1,992 | 218,981 | 1,034,677 | 1 M to 1 M (-0.19 %) |
Aug 16 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 104.97 | 29,924 | 3,141,122 | 1,036,669 | 1.1 M to 1 M (-2.81 %) |
Aug 16 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 105.58 | 24,624 | 2,599,802 | 1,066,593 | 1.1 M to 1.1 M (-2.26 %) |
Aug 16 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 106.36 | 56,278 | 5,985,728 | 1,091,217 | 1.1 M to 1.1 M (-4.90 %) |
Aug 16 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 107.12 | 29,174 | 3,125,119 | 1,147,495 | 1.2 M to 1.1 M (-2.48 %) |
Aug 07 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 116.87 | 2,919 | 341,144 | 1,176,669 | 1.2 M to 1.2 M (-0.25 %) |
Aug 01 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 110.86 | 2,737 | 303,424 | 1,179,588 | 1.2 M to 1.2 M (-0.23 %) |
Aug 01 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 121.01 | 6,112 | 739,613 | 1,182,325 | 1.2 M to 1.2 M (-0.51 %) |
Aug 01 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 120.09 | 39,099 | 4,695,399 | 1,188,437 | 1.2 M to 1.2 M (-3.19 %) |
Aug 01 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 119.74 | 10,001 | 1,197,520 | 1,227,536 | 1.2 M to 1.2 M (-0.81 %) |
Aug 01 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 118.27 | 17,376 | 2,055,060 | 1,237,537 | 1.3 M to 1.2 M (-1.38 %) |
Aug 01 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 117.24 | 10,817 | 1,268,185 | 1,254,913 | 1.3 M to 1.3 M (-0.85 %) |
Aug 01 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 116.11 | 27,900 | 3,239,469 | 1,265,730 | 1.3 M to 1.3 M (-2.16 %) |
Aug 01 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 114.85 | 100 | 11,485 | 1,293,630 | 1.3 M to 1.3 M (-0.01 %) |
Aug 01 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 113.12 | 200 | 22,624 | 1,293,730 | 1.3 M to 1.3 M (-0.02 %) |
Aug 01 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 112.56 | 4,200 | 472,752 | 1,293,930 | 1.3 M to 1.3 M (-0.32 %) |
Aug 01 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 111.04 | 6,125 | 680,120 | 1,298,130 | 1.3 M to 1.3 M (-0.47 %) |
Aug 01 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 110.53 | 50,967 | 5,633,383 | 1,304,255 | 1.4 M to 1.3 M (-3.76 %) |
Aug 01 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 109.56 | 37,103 | 4,065,005 | 1,355,222 | 1.4 M to 1.4 M (-2.66 %) |
May 15 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 107.48 | 2,333 | 250,751 | 1,361,212 | 1.4 M to 1.4 M (-0.17 %) |
May 15 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 106.32 | 6,566 | 698,097 | 1,363,545 | 1.4 M to 1.4 M (-0.48 %) |
May 15 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 105.38 | 22,214 | 2,340,911 | 1,370,111 | 1.4 M to 1.4 M (-1.60 %) |
May 14 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 104.94 | 6,220 | 652,727 | 1,392,325 | 1.4 M to 1.4 M (-0.44 %) |
May 14 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 100.12 | 35,000 | 3,504,200 | 1,398,545 | 1.4 M to 1.4 M (-2.44 %) |
Apr 19 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 95.04 | 35,000 | 3,326,400 | 1,433,545 | 1.5 M to 1.4 M (-2.38 %) |
Apr 12 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 100.24 | 26,700 | 2,676,408 | 1,468,545 | 1.5 M to 1.5 M (-1.79 %) |
Apr 03 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 99.97 | 8,300 | 829,751 | 1,495,245 | 1.5 M to 1.5 M (-0.55 %) |
Apr 03 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 95.00 | 35,000 | 3,325,000 | 1,503,545 | 1.5 M to 1.5 M (-2.27 %) |
Feb 08 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | A | 93.83 | 220,000 | 20,642,600 | 220,000 | |
Feb 08 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Grant | A | 0.00 | 16,500 | 0 | 1,538,545 | 1.5 M to 1.5 M (+1.08 %) |
Feb 06 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 96.22 | 180 | 17,320 | 1,522,045 | 1.5 M to 1.5 M (-0.01 %) |
Feb 06 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 96.48 | 7,800 | 752,544 | 1,522,225 | 1.5 M to 1.5 M (-0.51 %) |
Feb 06 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 95.86 | 3,900 | 373,854 | 1,530,025 | 1.5 M to 1.5 M (-0.25 %) |
Jan 30 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 94.32 | 2,682 | 252,966 | 1,533,925 | 1.5 M to 1.5 M (-0.17 %) |
Jan 30 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 94.50 | 2,560 | 241,920 | 1,536,607 | 1.5 M to 1.5 M (-0.17 %) |
Jan 17 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 99.16 | 181 | 17,948 | 1,539,167 | 1.5 M to 1.5 M (-0.01 %) |
Jan 17 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 98.58 | 34,819 | 3,432,457 | 1,539,348 | 1.6 M to 1.5 M (-2.21 %) |
Jan 11 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 99.96 | 27,197 | 2,718,612 | 1,574,167 | 1.6 M to 1.6 M (-1.70 %) |
Jan 04 2013 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 99.93 | 7,803 | 779,754 | 1,601,364 | 1.6 M to 1.6 M (-0.48 %) |
Dec 20 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 95.68 | 35,000 | 3,348,800 | 1,609,167 | 1.6 M to 1.6 M (-2.13 %) |
Nov 30 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 4.03 | 13,515 | 54,465 | 0 | |
Nov 30 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 94.97 | 35,000 | 3,323,950 | 1,644,167 | 1.7 M to 1.6 M (-2.08 %) |
Nov 30 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 94.96 | 13,515 | 1,283,384 | 1,679,167 | 1.7 M to 1.7 M (-0.80 %) |
Nov 30 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 4.03 | 13,515 | 54,465 | 1,692,682 | 1.7 M to 1.7 M (+0.80 %) |
Nov 02 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 4.03 | 3,293 | 13,271 | 13,515 | |
Nov 02 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 4.03 | 2,022 | 8,149 | 0 | |
Nov 02 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 94.98 | 2,667 | 253,312 | 1,679,167 | 1.7 M to 1.7 M (-0.16 %) |
Nov 02 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 95.00 | 5,315 | 504,925 | 1,681,834 | 1.7 M to 1.7 M (-0.32 %) |
Nov 02 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 4.03 | 5,315 | 21,419 | 1,687,149 | 1.7 M to 1.7 M (+0.32 %) |
Oct 03 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 4.03 | 18,070 | 72,822 | 2,022 | |
Oct 03 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 115.92 | 300 | 34,776 | 1,681,834 | 1.7 M to 1.7 M (-0.02 %) |
Oct 03 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 115.26 | 17,770 | 2,048,170 | 1,682,134 | 1.7 M to 1.7 M (-1.05 %) |
Oct 03 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 4.03 | 18,070 | 72,822 | 1,699,904 | 1.7 M to 1.7 M (+1.07 %) |
Sep 28 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 4.03 | 43,100 | 173,693 | 20,092 | |
Sep 28 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 5.82 | 33,000 | 192,060 | 0 | |
Sep 28 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 10.29 | 9,720 | 100,019 | 0 | |
Sep 28 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 8.18 | 32,064 | 262,284 | 0 | |
Sep 28 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 5.10 | 7,500 | 38,250 | 0 | |
Sep 28 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 10.29 | 9,720 | 100,019 | 1,681,834 | 1.7 M to 1.7 M (+0.58 %) |
Sep 28 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 111.44 | 76,100 | 8,480,584 | 1,672,114 | 1.7 M to 1.7 M (-4.35 %) |
Sep 28 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 4.03 | 43,100 | 173,693 | 1,748,214 | 1.7 M to 1.7 M (+2.53 %) |
Sep 28 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 5.82 | 33,000 | 192,060 | 1,705,114 | 1.7 M to 1.7 M (+1.97 %) |
Sep 28 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 8.18 | 32,064 | 262,284 | 1,672,114 | 1.6 M to 1.7 M (+1.96 %) |
Sep 28 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 5.10 | 7,500 | 38,250 | 1,640,050 | 1.6 M to 1.6 M (+0.46 %) |
Sep 28 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 114.44 | 1,008 | 115,356 | 1,632,550 | 1.6 M to 1.6 M (-0.06 %) |
Sep 28 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 113.16 | 31,826 | 3,601,430 | 1,633,558 | 1.7 M to 1.6 M (-1.91 %) |
Sep 28 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 111.96 | 34,166 | 3,825,225 | 1,665,384 | 1.7 M to 1.7 M (-2.01 %) |
Sep 28 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Gift | G | 0.00 | 26,468 | 0 | 1,699,550 | 1.7 M to 1.7 M (+1.58 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 5.82 | 35,000 | 203,700 | 27,332 | |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 4.42 | 27,000 | 119,340 | 0 | |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 104.96 | 2,470 | 259,251 | 1,673,082 | 1.7 M to 1.7 M (-0.15 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Gift | G | 0.00 | 204,088 | 0 | 1,675,552 | 1.9 M to 1.7 M (-10.86 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 106.14 | 2,272 | 241,150 | 1,879,640 | 1.9 M to 1.9 M (-0.12 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 109.47 | 16,606 | 1,817,859 | 1,881,912 | 1.9 M to 1.9 M (-0.87 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 108.40 | 18,394 | 1,993,910 | 1,898,518 | 1.9 M to 1.9 M (-0.96 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 106.46 | 2,232 | 237,619 | 1,916,912 | 1.9 M to 1.9 M (-0.12 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 105.85 | 24,768 | 2,621,693 | 1,919,144 | 1.9 M to 1.9 M (-1.27 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 5.82 | 35,000 | 203,700 | 1,943,912 | 1.9 M to 1.9 M (+1.83 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 4.42 | 27,000 | 119,340 | 1,908,912 | 1.9 M to 1.9 M (+1.43 %) |
Jul 10 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 4.42 | 53,000 | 234,260 | 1,500 | |
Jul 10 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 2.69 | 8,344 | 22,445 | 0 | |
Jul 10 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 2.69 | 46,656 | 125,505 | 0 | |
Jul 10 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 101.83 | 2,100 | 213,843 | 1,881,912 | 1.9 M to 1.9 M (-0.11 %) |
Jul 10 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 100.98 | 11,163 | 1,127,240 | 1,884,012 | 1.9 M to 1.9 M (-0.59 %) |
Jul 10 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 100.30 | 94,737 | 9,502,121 | 1,895,175 | 2 M to 1.9 M (-4.76 %) |
Jul 10 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 4.42 | 53,000 | 234,260 | 1,989,912 | 1.9 M to 2 M (+2.74 %) |
Jul 10 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 2.69 | 55,000 | 147,950 | 1,936,912 | 1.9 M to 1.9 M (+2.92 %) |
Feb 06 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 78.88 | 275,410 | 21,724,341 | 275,410 | |
Feb 06 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 0.00 | 36,000 | 0 | 1,881,912 | 1.8 M to 1.9 M (+1.95 %) |
Jan 30 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 74.51 | 9,569 | 712,986 | 1,845,912 | 1.9 M to 1.8 M (-0.52 %) |
Jan 30 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 74.41 | 2,264 | 168,464 | 1,855,481 | 1.9 M to 1.9 M (-0.12 %) |
Jan 11 2012 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 75.00 | 2,226 | 166,950 | 1,857,745 | 1.9 M to 1.9 M (-0.12 %) |
Nov 17 2011 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 2.69 | 5,000 | 13,450 | 8,344 | |
Nov 17 2011 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 6.04 | 19,884 | 120,099 | 0 | |
Nov 17 2011 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 2.69 | 5,000 | 13,450 | 1,845,087 | 1.8 M to 1.8 M (+0.27 %) |
Nov 17 2011 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 67.31 | 2,282 | 153,601 | 1,840,087 | 1.8 M to 1.8 M (-0.12 %) |
Nov 17 2011 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 66.72 | 17,602 | 1,174,405 | 1,842,369 | 1.9 M to 1.8 M (-0.95 %) |
Nov 17 2011 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 6.04 | 19,884 | 120,099 | 1,859,971 | 1.8 M to 1.9 M (+1.08 %) |
Oct 28 2011 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 2.69 | 20,000 | 53,800 | 13,344 | |
Oct 28 2011 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 6.04 | 79,536 | 480,397 | 0 | |
Oct 28 2011 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 2.69 | 20,000 | 53,800 | 1,840,087 | 1.8 M to 1.8 M (+1.10 %) |
Oct 28 2011 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 65.86 | 25,920 | 1,707,091 | 1,820,087 | 1.8 M to 1.8 M (-1.40 %) |
Oct 28 2011 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 66.69 | 53,616 | 3,575,651 | 1,846,007 | 1.9 M to 1.8 M (-2.82 %) |
Oct 28 2011 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 6.04 | 79,536 | 480,397 | 1,899,623 | 1.8 M to 1.9 M (+4.37 %) |
Jul 28 2011 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 57.27 | 2,285 | 130,862 | 1,820,087 | 1.8 M to 1.8 M (-0.13 %) |
Jul 12 2011 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 50.00 | 2,175 | 108,750 | 1,822,372 | 1.8 M to 1.8 M (-0.12 %) |
Feb 04 2011 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | A | 85.31 | 215,000 | 18,341,650 | 215,000 | |
Feb 04 2011 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Grant | A | 0.00 | 24,000 | 0 | 913,361 | 889.4 K to 913.4 K (+2.70 %) |
Jan 28 2011 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 84.70 | 4,544 | 384,877 | 889,361 | 893.9 K to 889.4 K (-0.51 %) |
Jan 18 2011 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 82.66 | 1,293 | 106,879 | 893,905 | 895.2 K to 893.9 K (-0.14 %) |
Jan 12 2011 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 81.27 | 1,131 | 91,916 | 895,198 | 896.3 K to 895.2 K (-0.13 %) |
Dec 17 2010 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Gift | G | 0.00 | 13,000 | 0 | 896,329 | 909.3 K to 896.3 K (-1.43 %) |